An object of the present invention is to provide a method which is able to prevent or improve the progress of myolytic diseases such as muscular dystrophy. Such an object is able to be solved by a method where an effective dose of an inhibitor for hematopoietic prostaglandin D synthase (H-PGDS) or an antagonist to prostaglandin D receptor is administered to a patient who needs it. The present invention also provides a method for screening compounds which are able to prevent the progress of myolytic diseases and to improve it using human H-PGDS overexpressed transgenic mice.

 
Web www.patentalert.com

< 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof

< 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders

> Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase

> Small molecule inhibitors of rotamase enzyme activity
~ 00225